EGFR exon 18 delE709T710insD mutated stage IV non-small cell lung cancer treated with osimertinib: a case report

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Osimertinib treatment response in a patient with lung adenocarcinoma harboring two rare EGFR mutations: A case report2024 · 2 citations
2. 2Lung adenocarcinoma harboring uncommon EGFR exon 19 deletion L747_T751del and in cis K754E mutation: a case report and literature review2025
3. 3Characterization of a rare EGFR resistance mutation in a lung cancer patient with a long response to osimertinib: case report2026
4. 4C79-12 Non-small Cell Lung Cancer With EGFR D770_n771insg Demonstrating an Extended Response to Osimertinib: Case Report2026
5. 5Targeting the Uncommon: A Case Report of Osimertinib Response in Advanced NSCLC Patient with Dual EGFR (E701fs and L702fs) Frameshift Deletions2026